What percent of RXRX is sold short?

54.1% of Recursion (RXRX) trading volume was short last week. Track days-to-cover and borrow rate against insider and hedge fund flow.

Is RXRX a short squeeze candidate?

Compare short volume, days-to-cover, and borrow rate to insider buying — when insiders accumulate against heavy short interest, the squeeze setup gets stronger.

How is short volume different from short interest?

Short volume is daily shorting activity reported by FINRA; short interest is the bi-monthly snapshot of outstanding short positions. We track both for Recursion (RXRX).

RXRX Short Volume Hit 54.1%

$4.12

+0.05 (+1.23%)

Weekly Expected Move ±12.2%

$3 $4 $4 $5 $5

NASDAQ · Healthcare · Biotechnology · Tech Score Strong Buy · Power 65 · $2.2B mcap · 409M float · 5.00% daily turnover · Short 54% of daily vol

Short Volume Summary

2026-10-01

53.2%

Short Ratio

of total volume

55.7%

20-Day Avg

50.7%

50-Day Avg

▼ Falling

5-Day Trend

4.2M

Short Volume

8.0M

Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-01

Exchange	Short Volume	Total Volume	Short %
NASDAQ	4,032,039	7,472,563	54.0%
NYSE	193,445	383,122	50.5%
BATS	14,586	120,213	12.1%

RXRX Short Interest

Short Volume Summary

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

Sign in to InsiderStreet